[Evaluation of the efficacy of TS-1 for peritoneal dissemination of gastric cancer using a newly-developed animal model].
Mori
Takuji
T
Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University, Suita, Japan.
Fujiwara
Yoshiyuki
Y
Takiguchi
Shuji
S
Yasuda
Takushi
T
Tamura
Shigeyuki
S
Yano
Masahiko
M
Monden
Morito
M
D000284:Administration, Oral; D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D004195:Disease Models, Animal; D004338:Drug Combinations; D004341:Drug Evaluation; D051379:Mice; D008819:Mice, Nude; D010094:Oxonic Acid / Q000008:administration & dosage*; D010534:Peritoneal Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D011725:Pyridines / Q000008:administration & dosage*; D013274:Stomach Neoplasms / Q000473:pathology*; D005641:Tegafur / Q000008:administration & dosage*
D000964:Antimetabolites, Antineoplastic; D004338:Drug Combinations; D011725:Pyridines; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid